Nucleic Acids ResearchMolecular BiologyPeer-reviewed journal article
The inflammasome sensor NLRP3 interacts with REV7 to maintain genome integrity through homologous recombination
Delphine Burlet, Md Muntaz Khan, Sabine Hacot, Hannes ButhmanniD, Léa BardouletiD, Anne‐Laure HuberiD, Julie Gorry, Bastian Föhr, Bernard S. LópeziD, Yohann CoutéiD, Alex C. FaeseniD, Matthias GeyeriD, Agnès TissieriD, Virginie PétrilliiD
- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 30%
Abstract
DNA double strand break (DSB) is a highly toxic lesion that can generate genome instability, a major source of tumorigenesis. DSBs are mainly repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). The selection of the DSB repair pathway primarily depends on the DNA resection of the DSB ends. Indeed, HR is initiated by resection at the DSB generating 3 single stranded extension. The shieldin complex prevents resection fostering DSB repair toward NHEJ. Here, we reveal that the inflammasome sensor NLRP3 facilitates DNA end resection to promote the HR pathway in an inflammasome-independent manner. Strikingly, NLRP3 silencing decreases HR efficiency, as evidenced by RAD51 foci and functional HR assays. Mechanistically, we describe that NLRP3 interacts with REV7, a subunit of the shieldin complex, and its depletion increases REV7 recruitment to IR-induced DSBs. Similar to cancer cells harboring HR mutated genes, we find that NLRP3 deficient cells are sensitive to PARP inhibitors (PARPi) and exhibit an epistatic relationship with BRCA1 deficiency. Remarkably, loss of REV7 in NLRP3-depleted cells induces PARPi resistance by restoring HR. This study unravels the crucial role of the innate immune receptor NLRP3 in regulating the selection of DSB repair pathways to maintain genome integrity.
- organism: human
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LIN37-DREAM Prevents DNA End Resection and Homologous Recombination at DNA Double Strand Breaks in Quiescent Cells
B.-R. Chen, Y. Wang, … B. P. Sleckman·bioRxiv·Apr 21, 2021
- NLRP3 controls ATM activation in response to DNA damage.
V. PETRILLI, M. Bodnar-Wachtel, … J. Hall·bioRxiv·May 12, 2020
- FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.
A. Orthwein, S. Findlay, … H. Kuasne·bioRxiv·Jul 11, 2018
- PARP inhibitor synthetic lethality reveals homologous recombination sub-pathway architecture
Ki Choi Chan, Anastasiia Kovina, … Markus Löbrich·bioRxiv·Mar 7, 2026
- Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1/53BP1 Double-deficient Cells by Exposing ssDNA Gaps
M. Paes Dias, V. Tripathi, … J. Jonkers·bioRxiv·Mar 24, 2021
- HIPK2 regulates homology-directed DNA repair and PARP inhibitor sensitivity
Patrick Weyerhäuser, Pierre‐Olivier Frappart, … Thomas G. Hofmann·bioRxiv·Jun 1, 2026